SV

Street Verdict

Analyst Scorecard

A record of what Sumeet Bagadia said publicly, with the source. Not advice.

“Recommends buying Poly Medicure at ₹2775, targeting ₹2970 with a stop-loss at ₹2670. The stock delivered a strong bullish performance with robust volumes, marking a decisive breakout from prolonged consolidation and shifting to a clear structure of higher highs and higher lows, indicating renewed investor confidence.”

Sumeet Bagadia’s track record (trackable calls only): 1528 graded calls · 95% CI 32–37%

Poly Medicure LtdBullishCalled 07 May 2025Graded 09 May 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹2,775, as stated.

Target ₹2,970, stop ₹2,670, as stated.

No time frame is stated, so it is tracked until a close reaches ₹2,970 or ₹2,670: there is no fixed window.

The stop ₹2,670 was reached on a close before the target ₹2,970. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹2674.8 on 2025-05-08 (stated entry ₹2775, DIP_LIMIT entry, filled); stop ₹2670 breached at close ₹2526.8 on 2025-05-09. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking Poly Medicure Ltd since this call

1-year tracking window
Read the original articleSee Sumeet Bagadia’s full track record